A traveler infected with measles passed through Philadelphia International Airport, marking the second public exposure site identified in the city. The individual moved through terminals B and F and utilized connecting walkways for terminals C, D, and E from 7:25 p.m. on Sept. 13 to 12:05 a.m. on Sept. 14, officials announced Friday. Health authorities confirmed the traveler did not exit the airport facility during the visit.
Airport Exposure Details and Public Health Guidance
The airport transit is entirely separate from a prior measles exposure reported at the Children’s Hospital of Philadelphia on Sept. 11, which affected areas including the neonatal intensive care unit, according to municipal health data. Passengers present in the designated airport terminals during the exposure window who lack verified measles immunity, are unsure of their vaccination history, are pregnant without immunity, or are immunocompromised must contact a healthcare provider immediately, city health officials advised.
Early clinical indicators typically feature a fever, runny nose, cough, and red, watery eyes, which are followed by a characteristic rash. Severe complications from the virus can include pneumonia, acute brain infection, and death.
Broader Outbreak Context and Vaccination Metrics
Pennsylvania has recorded 792 measles cases this year, resulting in 155 hospitalizations and four deaths, based on state tracking statistics. On a national level, Centers for Disease Control and Prevention data shows 3,471 cases nationwide this year, driven by a drop in kindergarten MMR vaccination rates to 92.4% for the 2025–2026 school year, down from 95.2% during the 2019–2020 term.
Pro Tip: Health authorities remind the public that infants under one year old cannot receive the MMR vaccine, making community herd immunity and adult vaccination vital to protect vulnerable populations. Over 40,000 doses of the MMR vaccine have been administered across the commonwealth in the past month alone, according to municipal health communications.
The measles virus spreads easily through airborne droplets when an infected person coughs, sneezes, or talks, and the pathogen can linger in a room or airspace for up to two hours after an infected person departs. The standard medical defense is the two-dose MMR vaccine series, administered first at 12 to 15 months and again between ages four and six, which provides roughly 97% lifetime protection, according to federal and local health guidelines.
Official Statements on Immunity and Prevention
“The individual with measles was traveling through Philadelphia and did not leave the airport,” health officials stated in an advisory. Philadelphia Health Commissioner Dr. Palak Raval-Nelson emphasized the role of community immunization in managing the current spread. “Every Philadelphian who is fully vaccinated has little to fear from the situation at CHOP and the airport,” Dr. Raval-Nelson said, adding that vaccinated residents help safeguard vulnerable infants and immunocompromised neighbors.
Individuals who believe they were exposed or who display active symptoms should contact a primary care provider immediately or reach out to the Department of Health toll-free hotline at 877-PA-HEALTH (877-724-3258), or visit phila.gov/measles for further guidance.
Frequently Asked Questions
What terminals were affected at Philadelphia International Airport?
The infected traveler visited terminals B and F and used connective pathways for terminals C, D, and E between 7:25 p.m. on Sept. 13 and 12:05 a.m. on Sept. 14, according to the Philadelphia Department of Public Health.
Is the airport exposure connected to the CHOP incident?
No. City health officials confirmed that the airport exposure is entirely separate from the Sept. 11 exposure reported at the Children’s Hospital of Philadelphia.
Who is considered immune to measles?
Health officials note that individuals who are fully vaccinated with two doses of the MMR vaccine, those born before 1957, or those who have previously contracted and recovered from measles are generally considered immune.
What symptoms should travelers monitor?
Early symptoms include a fever, cough, runny nose, and red, watery eyes, followed by a distinct skin rash appearing days later.
Call to Action: Are you up to date on your immunization records? Share your thoughts on public health safety measures in the comments below, subscribe to our newsletter for urgent health updates, or explore our archives for more local news coverage.